World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Scientific Indexing Services (SIS), Indian citation Index (ICI), Directory of Research Journals Indexing, Scintific journal impact factorScientific Journal Impact Factor (SJIF), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Cosmos Impact Factor, IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Research Bible, Fuchu, Tokyo. JAPAN, Scholar Article Journal Index (SAJI), Scope Database, Academia, 

Abstract

A COMPREHENSIVE REVIEW OF INHALATION INSULIN: EVALUATING ITS EFFICACY, SAFETY PROFILE, MECHANISTIC INSIGHTS, CLINICAL APPLICATIONS, AND POTENTIAL TO TRANSFORM DIABETES MANAGEMENT AND PATIENT ADHERENCE IN THE CONTEXT OF EVOLVING THERAPEUTIC STRATEGIES

Agilandeswari Devarajan, Sagar, Pinnu Sathish Kumar, Kanika, Anil Kumar, Arpan Dutta, Manoj Kumar Katual , Yash Srivastav and Uriti Sri Venkatesh*

ABSTRACT

Diabetes mellitus (DM) is a chronic metabolic disorder affecting millions worldwide, requiring effective glycemic control to prevent complications. Insulin therapy is the cornerstone of diabetes management, yet traditional subcutaneous injections pose challenges related to patient adherence, injection discomfort, and delayed pharmacokinetics. Inhaled insulin emerges as a promising alternative, offering a non-invasive, rapid-acting approach that mimics endogenous insulin secretion more closely than subcutaneous administration. Despite its potential, early formulations like Exubera faced market failure due to bulky device design and safety concerns. However, newer advancements, particularly Afrezza, have demonstrated improved bioavailability, better patient adherence, and faster onset of action. This review explores the mechanism of action, pharmacokinetics, clinical efficacy, safety profile, delivery technologies, regulatory challenges, and economic considerations of inhaled insulin. Furthermore, it discusses patient adherence trends, emerging AI-driven insulin monitoring systems, and future perspectives in diabetes management. Although inhaled insulin shows promise in improving patient compliance and glycemic control, challenges such as cost-effectiveness, long-term pulmonary safety, and insurance coverage remain critical barriers. Advancements in nanoparticle-based insulin formulations, smart inhalers, and personalized medicine approaches may further enhance the feasibility and adoption of inhaled insulin in clinical practice.

[Full Text Article]   [Download Certificate]

WJPLS CITATION

  All Since 2020
 Citation  590  424
 h-index  12  10
 i10-index  17  14

INDEXING

NEWS & UPDATION

    A PHP Error was encountered

    Severity: Notice

    Message: Undefined variable: news

    Filename: views/right_panel.php

    Line Number: 79

    A PHP Error was encountered

    Severity: Warning

    Message: Invalid argument supplied for foreach()

    Filename: views/right_panel.php

    Line Number: 79

BEST ARTICLE AWARDS

World Journal of Pharmaceutical and life sciences is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here